# AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

> **NCT06708910** · — · RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 460 (estimated)

## Conditions studied

- HER2 Positive Breast Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06708910
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2031-03
- **Final completion:** 2031-07
- **Target enrollment:** 460 (ESTIMATED)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708910, "AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06708910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*